Universal cancer cure: scientists create ready-to-use CAR-NK cells

The researchers demonstrated that these modified CAR-NK cells maintain activity for three weeks, while standard cells are quickly rejected. The new cells also help avoid the dangerous inflammatory effect often seen in cancer immunotherapy. The next step will be clinical trials on humans to confirm the effectiveness of this technology and explore the possibility of its widespread use.

Researchers from the Massachusetts Institute of Technology and Harvard Medical School have developed CAR-NK cells that can effectively destroy cancer cells without being rejected by the body. This technology may become the basis for universal immunotherapy against cancer in the future. The scientists added chimeric antigen receptors (CAR) to natural killer (NK) cells to enhance their ability to attack cancer tumors.

Scientists from the Massachusetts Institute of Technology and Harvard Medical School have developed new CAR-NK cells that may aid in the fight against cancer. These modified immune system cells could represent an important step in the development of universal immunotherapy against cancer, providing a more effective and safer way to combat this disease. Research has shown promising results, and the next step will be clinical trials to determine the potential for broad use of this technology in medical practice.